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ABSTRACT
Mammalian mitochondria contain their own
genome that is almost fully transcribed from both
strands, generating polycistronic RNA units that
are processed and matured. The mitochondrial
mRNA is modified by oligo- or polyadenylation at
the 30 termini, but the exact function of this
post-transcriptional addition is unclear. Current
debate focuses on the role of polyadenylation in
transcript stability. An equally likely function that
has received little attention is that, as in the
cytosol of eukaryotes, polyadenylation facilitates
translation in the mitochondrion. To address
this issue, we have targeted cytosolic proteins
to the mitochondrion, a poly(A) specific 30
exoribonuclease, mtPARN, and a poly(A)binding
protein, mtPABP1. Removal of the 30 adenylyl
extensions had a variable effect on mt-mRNA
steady-state levels, increasing (MTND1, 2, 5) or
decreasing (MTCO1, 2, RNA14) certain species
with minimal effect on others (RNA7, MTND3).
Translation was markedly affected, but interpreta-
tion of this was complicated by the concomitant
30 truncation of the open reading frame in most
cases. Coating of the poly(A) tail by mtPABP1,
however, did not lead to transcript decay
but caused a marked inhibition of mitochondrial
translation. These data are consistent with
endogenous RNA-binding factor(s) interacting with
the poly(A) to optimize mitochondrial protein
synthesis.
INTRODUCTION
Every nucleated human cell contains many hundreds or
thousands of copies of the mitochondrial genome,
mtDNA. This small molecule is almost fully transcribed
from both strands, producing polycistronic RNA units
that are co-transcriptionally processed and matured into
the three standard classes, mitochondrial (mt)-ribosomal,
-transfer and -messenger RNA (1,2). Transcripts that
encode polypeptides (mt-mRNAs) are normally poly- or
oligoadenylated, a process that is required to produce the
UAA termination codon in 7 out of the 11 major
mt-mRNA species. Beyond this stop codon formation,
the function of this simple maturation event in mamma-
lian mitochondria is elusive (3,4). As has been well docu-
mented, polyadenylation is required to promote both
stability and translatability of mRNAs in the cytosol of
eukaryotes. In contradistinction, however, in plant
organelles and prokaryotes the addition of 30 adenylates
is a harbinger of RNA degradation. There is no such mat-
uration of mt-mRNAs in the budding yeast
Saccharomyces cerevisiae, although all species contain a
dodecamer sequence towards their 30 termini (5). Finally,
to confound the issue further, studies over the recently
identiﬁed Trypanosoma brucei kinetoplast poly(A)
polymerase KPAP1, revealed that short poly(A) tails are
required and suﬃcient to maintain the steady-state levels
of partially edited, fully edited and never-edited mRNAs,
whereas they are not involved in stabilizing pre-edited
mRNAs (6). Upon completion of the editing process, the
short poly(A) tails are extended as (A/U) heteropolymers
into structures previously thought to be long poly(A) tails.
Authors of this report implied that these A/U structures
could be essential for generating translationally compe-
tent, fully edited mRNAs.
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a microdeletion in the termination codon of one species of
mt-mRNA, RNA14, showed this species to be less stable
and carried a shortened poly(A) tail (7). Although this
appeared to support a role for the poly(A) tail in stability
of mt-mRNA, it was noted that the deadenylation was
translation dependent, suggesting that the lack of stability
may have been due to run through of the mitoribosome
into the tail, promoting the degradation of the
unprotected transcript. Conﬂicting results have been
reported using siRNA-based approaches to deplete the
natural human mitochondrial poly(A) polymerase (8,9).
In the former example, shortened poly(A) extensions
were reported not to aﬀect transcript stability, whilst the
latter reported decreased steady state levels of analysed
mt-mRNAs with a concomitant decrease in translation.
It is possible these contradictory results have been com-
plicated by the retention of at least a minor population of
polyadenylated mt-mRNA species, possibly implicating a
second poly(A) polymerase activity (10).
A second function that could be modulated by
polyadenylation is mitochondrial translation. In the
cytosol, a protein bridge is formed between poly(A)
binding factors and proteins that interact with the
507-methylguanosine cap (11). Mitochondrial mRNA do
not carry any 50 modiﬁcation and to date, there has
been no report of a mitochondrial poly(A) binding
protein. Bioinformatic analyses reveal no obvious candi-
date, although several metabolic mitochondrial enzymes
have been shown to be capable of binding RNA and of
poly(A) sequences (12–14).
In an attempt to resolve whether oligo- or
polyadenylation of mt-mRNAs does indeed aﬀect the sta-
bility or translatability of transcripts, we have engineered
and mitochondrially targeted two human proteins that are
normally involved in mRNA expression in the cytosol:
PARN, a cytosolic 30–50 exoribonuclease with reported
speciﬁcity to poly(A) sequences and the cytosolic
poly(A) binding protein, PABPC1, reasoning that if a
known poly(A) binding protein could be re-directed to
the mitochondrial matrix it may be possible to compete
against endogenous proteins for the poly(A) sequence and
inhibit translation.
MATERIALS AND METHODS
Preparation of constructs
To initiate construction of an inducible FLAG-tagged
mitochondrially targeted PABP1 (mtPABP1), the open
reading frame of PABPC1 (clone MGC: 43692, IMAGE
5271298) was PCR ampliﬁed. PARN constructs were
polymerase chain reaction (PCR)-ampliﬁed from a
cDNA source equivalent to NM_002582 to generate an
amplicon containing the entire PARN open reading
frame (639aa). Subsequently, mtPARNC (430aa) was
produced. Both proteins also contained a C-terminal
FLAG tag. All cloning steps, vectors and primers used
for PCR amplication are given in Supplementary Data.
Site-directed mutagenesis of mtPABP1
Mutagenesis was performed with the QuikChange II
Site-Directed Mutagenesis Kit (Stratagene), essentially
following manufacturer’s guidelines. F337V mutant was
generated with the following pair of primers; F 50-gca
aag ggt ttg gtg ttg tat gtt tct cc-30,R5 0-gga gaa aca tac
aac acc aaa ccc ttt gc-30 and pcDNA5/FRT/TOmtPABP1
as the template. Y56V/F142V was generated by two
rounds of the mutagenesis. First with the following pair
of primers; F 50-ctt ggg cta cgc ggt tgt gaa ctt cca g-30,R
50-ctg gaa gtt cac aac cgc gta gcc caa g-30 and pcDNA5/
FRT/TO mtPABP1 as template. Second round, with the
primers introducing F142V (F 50-caa ggg cta tgg agt tgt
aca ctt tga gac-30,R5 0-gtc tca aag tgt aca act cca tag ccc
ttg-30) and pcDNA5/FRT/TO Y56V as template. All
mutations were conﬁrmed by sequencing of both DNA
strands.
Generating Flp-In
TM T-Rex
TM expression cell lines
HEK293 Flp-In
TM T-Rex
TM (HEK293T; Invitrogen) cells
were grown as a monolayer in DMEM (Sigma, D6429)
supplemented with 10% (v:v) FCS, 50mg/ml uridine and
non-essential amino acids (standard growth medium).
Untransfected HEK293T cells were maintained in
presence of blasticidin S (10mg/ml) and zeocin
(100mg/ml). The cultures were grown in vented ﬂasks at
37 C in a 5% CO2 humidiﬁed atmosphere. Medium was
replaced every 2–3 days.
To generate stable, inducible expression cell lines,
HEK293T were co-transfected with pcDNA5/FRT/TO
harbouring the mtPARN, mtPABP1 or mtLUC deriva-
tives, and pOG44 (Invitrogen) according to the manufac-
turer’s recommendations, using SuperFect (QIAGEN)
transfection reagent following the manufacturer’s
guidelines.
After transfection, cells were cultured in DMEM
(Sigma) with hygromycin B (100mg/ml) and blasticidin S
(10mg/ml). After approximately 3–4 weeks of selection
clonal foci were identiﬁed, transferred into separated
wells. Expression was induced by addition of tetracycline
(1mg/ml) to the growth medium for the indicated time.
Cell lysate and mitochondrial preparation
Production of mitochondria and cell lysates were as
described in (15). Proteinase K treatment was carried
out in a 50ml volume of isolation buﬀer lacking bovine
serum albumun (BSA) containing 50mg freshly isolated
mitochondria and proteinase K (20ng/ml ﬁnal).
Reactions were incubated on ice for 30min, stopped by
addition of phenylmethylsulphonyl ﬂuoride (PMSF;
1mM), mitochondria were washed twice in 1ml of the
isolation buﬀer (-BSA) and re-suspended in the desired
buﬀer. Where necessary, mitochondria were solubilized
by addition of Triton X-100 to 1% v:v.
RNA isolation and northern blot procedure
RNA was prepared by TRIZOL (Invitrogen) extraction
following manufacturer’s recommendations. Northerns
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PhosphorImager analysis (GE Healthcare).
Analysis of proteins by western blot and blue native gel
electrophoresis
After separation by standard sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE), protein
species were immobilized on polyvinylidene diﬂuoride
(PVDF) membrane (Immobilon-P, Millipore
Corporation) by wet transfer (500mA, 2.5h at 4 C) in
Towbin transfer buﬀer. Membranes were blotted with
appropriate primary antibodies [anti-FLAG M2 (Sigma);
anti-b-actin (Sigma); anti-MRPL3 (Abcam); anti-
MRPS18b (ProteinTech Group); anti-IF3mt; anti-porin
(Molecular Probes)]; monoclonals against COX2,
NDUFA9, NDUFB8, SDH 70K, core 2 complex III
(MitoSciences), followed by horseradish peroxidase
(HRP)-conjugated secondary antibodies (DAKO) and
visualised by ECL-plus (GE Healthcare). One-dimension
blue native gel electrophoresis was performed as described
in (17) with the modiﬁcation that 50mg protein was loaded
per lane.
Immunoaﬃnity puriﬁcation of FLAG tagged fusion
proteins and RNA isolation
Immunoprecipitations were performed using the FLAG
Tagged Protein Immunoprecipitation Kit (FLAGIPT-1
Sigma), essentially following manufacturer’s recom-
mendations. Typically, 1.5mg of proteinase-K-treated
mitochondria isolated from HEK293T cells expressing
mtPABP1 or mtLUC were re-suspended in 0.5ml of
lysis buﬀer (50mM Tris–HCl pH 7.4, 150mM NaCl,
1mM EDTA, 1% Triton X-100) supplemented with
Complete EDTA free Protease Inhibitor Cocktail
(Roche) and RNAguard (GE Healthcare). Lysis was per-
formed for 20min rotating at 4 C, followed by
centrifugation at 12000g for 10min to remove insoluble
material. Mitochondrial lysates were incubated with
anti-FLAG M2-Agarose Aﬃnity Gel (Sigma) and
incubated for 30min, rotating at 4 C. Unbound material
was removed by series of washes in 50mM Tris–HCl pH
7.4, 150mM NaCl, 50mg/ml heparin. Elution of bound
FLAG tagged recombinant protein was performed with
FLAG peptide (Sigma) for 45min at 4 C with constant
agitation.
To isolate RNA associated with FLAG tagged proteins,
the eluted fractions were subjected to Trizol (Invitrogen)
extraction. Equal volumes of extracted RNA were
analysed by northern blot. To remove any possible
DNA contaminations, RNA samples were treated with
1U of RNase-Free DNase I (Epicentre Biotechnologies)
for 30min at 37 C, phenol–chloroform extracted and
precipitated. Isolated RNA was reversed transcribed
using random hexamers and Superscript II preamplication
kit (Invitrogen) following manufacturer’s guidelines.
Mitochondrial poly(A)-tail length assay
The technique was performed as described in (7). The
additional primers used in this paper to analyse the fol-
lowing transcripts were as follows: MTCO1, ﬁrst primer,
(nt 7151–7170), nested radiolabelled primer (nt
7488–7504); MTCO2, ﬁrst primer (nt 8155–8172), nested
radiolabelled primer (nt 8265-8284); MTND4 ﬁrst
primer (nt 11717–11736), nested radiolabelled primer
(nt 12108–12125). An annealing temperature of 54 C
was used for all reactions except with MTCO2 ﬁrst
primer, which was 50 C.
RNA circularization assays
The RNA ligation was adapted from (18). Reactions were
performed in 12.5ml 50mM HEPES pH 8.3, 10mM
MgCl2, 3.5mM DTT, 3.4mM ATP, 1mg/ml BSA, 10%
DMSO, RNA (2mg), 20U T4 RNA Ligase (New England
Biolabs). After 3h at 37 C, reactions were phenol
extracted, ethanol precipitated, washed and re-suspended
in 25ml of DEPC-treated water. Reverse transcription was
eﬀected with Superscript II (Gibco BRL) and cDNA
generated with gene speciﬁc primers.
Primers for reverse transcription (RT) and subsequent
PCR were: MTND3 RT-50-aggccagacttagg and PCR
F-50-gagtgactacaaaaaggattagac/R-50-ctaggatgatgattaataag
aggg; MTCO2 RT-50-gtaaaggatgcgtag and PCR F-50-ctc
cttgacgttgacaatcgag/R-50-gcaggatagttcagacggtttc; RNA14
RT-50-gacgagtccgagg and PCR 50-gcccacttcttaccacaaggc/
R-50-acttgttgggtggtgattagtc.
Cell proliferation assays
Untransfected cells were used to assess the eﬀect of tetra-
cycline on cell viability. To measure growth in standard
growth conditions, HEK293T cells expressing mtPABP1
or mtLUC were induced for 5 days in standard growth
conditions prior to the assay. To measure growth in con-
ditions forcing oxidative respiration, cells were
pre-induced with 1mg/ml of tetracycline in standard
medium for 5 days. Cells were then transferred to
DMEM medium lacking glucose (Sigma) supplemented
with 10% (v:v) dialysed FCS, 0.9mg/ml galactose,
0.11mg/ml sodium pyruvate and 1mg/ml tetracycline for
24h before the assay. Cells were then plated in six-well
plates and grown with tetracycline in galactose (2 10
5/
plate) or glucose containing medium (1 10
5/plate). Cells
were harvested from replicate plates on alternate days and
total cell counts made using a Neubauer haemocytometer.
35S-metabolic labelling of mitochondrial proteins
This technique was adapted from (20) with some major
modiﬁcations. Stably transfected HEK293T cells
expressing mtPABP1 or mtLUC were induced with tetra-
cycline (1mg/ml) for 3 or 5 days prior to
35S labelling.
Growth medium was replaced with methionine/cysteine-
free DMEM (Sigma) supplemented with 2mML-
glutamine, 50mg/ml uridine and non-essential amino
acids. The cells were incubated for 2 10min in this
medium before transfer to fresh methionine/cysteine-free
DMEM (Sigma) medium containing 10% (v:v) dialysed
FCS and emetine dihydrochloride (100mg/ml, ﬁnal).
Cells were incubated for 10min before addition of
220mCi of [
35S]-methionine/cysteine mix (PerkinElmer
EasyTag express protein labelling mix, 1175Ci/mmol)
per millililtre of medium. Labelling was performed for
3734 Nucleic Acids Research, 2010,Vol.38, No. 11various amounts of time (10–45min) before replacing the
medium with chilled standard growth medium supple-
mented with 7.5mg/ml methionine for two short washes.
All protein samples (25–50mg) were separated by 15%
SDS-PAGE and products visualised and quantiﬁed with
a PhosphorImager system with ImageQuant software
(Molecular Dynamics, GE Healthcare).
RESULTS
Loss of poly(A) sequences has a variable eﬀect on
transcript stability
To determine the role of the 30 poly(A) tail on mRNA
stability, the 30–50 poly(A) speciﬁc exoribonuclease
PARN (uniprot O95453) was engineered to target
mitochondria in human HEK293T cells. The pcDNA5/
FRT/TO vector was manipulated to express a PARN
fusion protein with the widely used N-terminal
pre-sequence from Neurospora crassa ATP9 and
C-terminal FLAG tag as described in ‘Materials and
Methods’ section. To control for any eﬀects due to target-
ing of a soluble exogenous protein to mitochondria, a
similar design was used to generate a C-terminal FLAG
tagged mitochondrially directed luciferase, mtLUC.
Following induction of transfectants, both proteins were
shown to be localized within isolated mitochondria and
were resistant to exogenous protease K (Supplementary
Figure S1). During induction over a time course of
6 days, total RNA was isolated and analysed by
northern blot. As shown in Figure 1 (lanes 14–17),
mtPARN degrades mitochondrial RNA substantially.
Further, circularization assays followed by sequence
analysis showed the degradation to be solely from the
30 terminus as expected, but this did not stop at the end
of the poly(A) additions, continuing into the open reading
frames of most transcripts (data not shown). In addition,
as is shown with the 12S probe (mtRNR1), degradation is
restricted neither to the poly(A) sequences nor to
polyadenylated mt-mRNAs.
As partially degraded products were not observed to be
readenylated (data not shown), it was likely that degrada-
tion in this context was processive. To try and reduce
processivity without losing activity, we generated a
C-terminal truncated construct, exploiting the suggestion
that the C-terminal cap-binding domain may interact with
the R3H domain to increase processivity even in the
absence of the 50 cap structure (21). This protein,
mtPARNC, targeted successfully to mitochondria
(Supplementary Figure S1) and reduced the size of
mt-mRNA products as shown in Figure 1 (lanes 8–11).
Compared to mtPARN, little variation in steady-state
levels of mt-mRNAs were noted between Day 1 and 6 in
the time course, consistent with the relatively short
turnover of mt-mRNAs (16). Following mtPARNC
induction, sequence data of clones from numerous tran-
scripts conﬁrmed that all products retained the correct 50
terminus irrespective of what species was analysed,
but lost the majority of polyadenylated 30 extensions
(Supplementary Table S1). As shown in Figure 1B, loss
of the poly(A) extensions had a variable eﬀect on the
stability of mt-mRNA species, ranging from an average
increase in steady-state level of 368±17% for MTND2
during the 6-day induction, to a decrease to 41±3%
starting levels for MTCO2. MTND3 showed only a
minor variation of 114±12%. Levels of both mt-rRNA
species were also very minimally aﬀected (MTRNR1
115±2%; MTRNR2 115±5%).
Translation of truncated mt-mRNA
Polyadenylation of mt-mRNA, therefore, is not an
absolute requirement for stability in human mitochondria.
Is it possible that polyadenylation is necessary to promote
transcript translation? Full-length mtPARN severely
truncated most mt-mRNA species, degrading well
beyond the poly(A) termini and in to the open reading
frame (Figure 1). Further, both 12S (MTRNR1) and
16S mt-rRNA (MTRNR2, data not shown) are also
degraded. Consequently, no mitochondrial protein syn-
thesis occurs in these cells (Figure 1C, lane 4). Protein
synthesis in mitochondria containing mtPARNC
(Figure 1C, lane 3) is more informative but as
polyadenylation immediately abuts the termination
codon in nine ORFs, the exonucleolytic activity of
mtPARNC still extended into the ORF in most cases.
For example, all 21 MTND2 clones rescued post
mtPARNC expression had lost their termination
codon (Supplementary Table S1), although the ORF
remained almost intact. Interestingly, whilst translation
is clearly aﬀected presumably due to mitoribosomal
stalling, it is not lost completely. Sequences suggest that
the ND2 gene product that is observed in Figure 1C will
be minimally truncated and we speculate that the decrease
in translation is due to a problem with recycling as the
mitochondrial ribosome will be left without a codon to
translate in the A site. There are a limited number of
mRNA species that have 30 untranslated regions
(UTRs), amongst these are MTND5 and the upstream
ORFs (encoding ATP8 and ND4) of the two bicistronic
units RNA14 and RNA7. In these three cases, the coding
sequences were not degraded and so translation was rela-
tively spared. MTCO1 also has a 30 UTR and sequence
analysis revealed 96% of MTCO1 transcripts to have
retained both the stop codon and at least part of the
72-nt 30 UTR. Translation of MTCO1 however, was
markedly aﬀected but this may reﬂect the loss of potential
interactions with a translational activator as discussed
below.
The cytosolic poly(A) binding protein, PABP1, can be
targeted and imported into human mitochondria
As the loss of the termination codon from most transcripts
made it impossible to assess the role of polyadenylation
in translation, a second approach was employed.
Diﬃculties have also been previously reported where
siRNA-mediated depletion of the mitochondrial poly(A)
polymerase was unable to completely remove polya-
denylated extensions (8,10). As an alternate approach,
we reasoned that association of a targeted poly(A)
binding protein to mt-mRNA would compete for any
interaction that may be required for the poly(A)
Nucleic Acids Research, 2010,Vol.38, No. 11 3735extensions to mediate mitochondrial translation.
Therefore, to determine the eﬀect of coating the polya-
denylated termini of human mt-mRNA with an RNA-
binding protein, the major human cytosolic poly(A)
binding protein, PABPC1 (uniprot P11940), was engi-
neered to facilitate mitochondrial targeting and import
as described in the ‘Materials and Methods’ section
(mtPABP1). Following transfection, clones were identiﬁed
that expressed mtPABP1 and mtLUC in response to tet-
racycline induction. To conﬁrm mitochondrial localiza-
tion, mitochondria were isolated from induced cells and
subjected to protease K shaving. As shown in Figure 4B,
mtPABP1 located to the mitochondrial fraction and was
resistant to the addition of protease.
Expression of mtPABP1 causes a severe mitochondrial
phenotype
It was immediately noticeable that on induction of
mPABP1, growth media became highly acidic, suggesting
the cells were acidotic but on media replacement every
2 days there was only limited evidence of cell death. To
measure any growth defect likely to be due to
mitochondrial OXPHOS dysfunction, growth curves
were produced either with standard concentrations of
glucose as a carbon source, or in media substituting
glucose for galactose, which forces cells to depend more
heavily on oxidative phosphorylation for ATP produc-
tion. Initially, all cells were grown in glucose and
induced for 5 days in tetracycline. Cells were then
re-plated and grown in either glucose ( 1 10
5 cells/
well) or galactose (2 10
5 cells/well) media as detailed in
‘Materials and Methods’ section. As shown in Figure 2A
(upper panel), growth in glucose was similar, irrespective
of induction of either construct, providing that the growth
media was changed after every 2 days. In galactose,
however, growth was severely compromised but only in
cells expressing mtPABP1, suggestive of mtPABP1 expres-
sion causing a severe defect in oxidative metabolism
(Figure 2A, lower panel).
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Figure 1. (A) Induction of mtPARN causes a variable eﬀect on the steady-state level of mitochondrial transcripts. Stable HEK293T transfectants
expressing mtLUC (lanes 1–-6), mtPARN (lanes 13–18) or the C-terminal truncated mtPARN (mtPARNC, lanes 7–12) were induced the number of
days indicated and isolated RNA (10mg) was subjected to northern blot analysis with the indicated probes as detailed in ‘Materials and Methods’
section. Probe from transcript encoding b-actin (ACTB) was used a loading control. (B) Northern blots were performed with the indicated probes on
at least three independent RNA isolations following induction of mtPARNC. Quantiﬁcation of steady-state mt-RNA was calculated by
PhosphorImager analysis as a percentage of uninduced control. Probes were targeted against mt-rRNA or mt-mRNA encoding components of
respiratory chain complexes as indicated, below. (C) Induction of mtPARN aﬀects mitochondrial protein synthesis. Transfectants were induced for
2 days prior to in vivo mitochondrial protein synthesis with
35S methionine/cysteine for 30min as detailed. Equal amounts of mitochondrial lysate
(50mg) were separated through a 15% denaturing SDS-PAGE, the gel dried and exposed to PhosphorImager prior to visualization. Individual
polypeptides were designated by their mobility (20).
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on expression of mtPABP1
To determine why expression of mtPABP1 causes a respi-
ratory defect, cells were induced for varying periods of
time. Western blots of whole cell lysates were then
probed with antibodies speciﬁc to several members of
the respiratory chain. Figure 2B shows a substantial
decrease in subunits of complexes I (NDUFB8) and IV
(COX2) after the 5- and 8-day induction of mtPABP1.
The loss of nuclear encoded complex I subunit
(NDUFB8) is likely to reﬂect the instability of the
complex due to the loss of mtDNA encoded components
as evidenced by lack of intact complex I detected by blue
native gel electrophoresis. A depletion of complex III was
also noted, although, SDHA, the 70-kDa FAD containing
subunit of the entirely nuclear encoded complex II, did not
display any signiﬁcant changes in steady state level.
Whole-cell respirometry was also performed with cells
expressing mtPABP1 or mtLUC for 8 days as detailed in
‘Materials and Methods’ section and (19) (Figure S2A).
Resting rates of oxygen consumption show a decrease for
the mtPABP1 expressors, with the consumption being less
coupled to ATP production than the control, consistent
with proton slip or electron/proton leak, potentially
through partially assembled OXPHOS complexes.
Rotenone insensitive respiration is also increased in the
mtPABP1 expressor, potentially due to increased ﬂux
through complex II, by-passing the residual complex I.
mtPABP1 binds to mitochondrial mRNA
These data are likely to be due to mtPABP1 binding to the
polyadenylated extensions of mt-mRNA but this had not
been formally shown. To conﬁrm binding to the poly(A)
termini, total RNA was extracted from cells expressing
mtPABP1 at various time points and subjected to
mitochondrial poly(A) tail analysis (7). Three representa-
tive mt-mRNAs are shown for the uninduced cells where
the majority of poly(A) extensions are between 40 and
60nt (Figure 3A, lanes 3, 8 and 12). After a 2-day induc-
tion of mtPABP1, this tail became shortened, with two
subpopulations predominating, one of 30–40nt and an
oligoadenylated population of 10–20nt (see MTCO1,
2 and RNA7 Figure 3A). This alteration in proﬁle is con-
sistent with mtPABP1 either displacing any endogenous
binding protein, with the unprotected extension being
trimmed or that mtPABP1 binding prevents further exten-
sion by the relevant poly(A) polymerase. The two
observed lengths of poly(A) tails may reﬂect the footprint
of the binding factor. In vitro studies revealed that
cytosolic PABPs from various organisms form a repeating
unit covering 27A residues (22), but the minimal binding
site requires 12 adenosines (23,24).
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transfectants (Glu uninduced, upper panel; Gal uninduced, lower panel) were seeded and counted in a similar fashion. (B) Samples were prepared
from transfectants expressing mtLUC (L, lanes 3 and 5) or mtPABP1 (P, lanes 2 and 4) for the indicated times and subjected to western blotting
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bind mt-mRNA, the protein was immunoprecipitated
from mitochondrial fractions prepared from cells after a
3-day induction as detailed in ‘Materials and Methods’
section. Immunoprecipitated mtPABP1-FLAG was then
denatured and associated nucleic acids extracted. Bound
mt-mRNA was quantiﬁed either directly, by northern blot
(Figure 3B) or reverse-transcribed and cDNA subjected to
qPCR (Table S2). A substantial enrichment was noted for
all mitochondrial transcripts analysed, conﬁrming that
mtPABP1 is able to interact with mt-mRNA. An enrich-
ment of 12S mt-rRNA, however, was also noted. Western
blotting of the eluates from the immunoprecipitations
showed evidence of large and small mitoribosomal
subunit proteins (Supplementary Figure S2B) from
mtPABP1-FLAG, alone. Taken together, these data are
consistent with mtPABP1 associating with polyadenylated
mRNA when loaded onto mitoribosomes, although
non-speciﬁc binding cannot be ruled out (see below).
Binding of mtPABP1 to the poly(A) tail causes inhibition
of translation
To assess whether binding of mtPABP1 could aﬀect
mitochondrial protein synthesis, in vivo translation was
performed with cells expressing mtPABP1 or mtLUC
(Figure 4A) in the presence of radiolabelled
35S methionine/cysteine for 15min (lanes 1, 2) or 45min
(lanes 3, 4) pulses. Protein synthesis was compromised by
expression of mtPABP1. Most mitochondrial transcripts
contain no 30 untranslated region and often require
polyadenylation to generate a UAA translation termina-
tion codon. Therefore, binding of mtPABP1 to the
poly(A) tail could occlude the stop codon of such tran-
scripts. ND5 and COX1 are encoded by transcripts con-
taining 30 UTRs of 568 and 72nt, respectively.
Additionally, the bi-cistronic units encoding ND4L/4
(RNA7) and ATP8/6 (RNA14) ensure that the ND4L
and ATP8 encoding open reading frames would also be
extended by relatively long 30 heteropolymeric sequences
prior to poly(A) extension. Synthesis of all these proteins
was clearly decreased (Figure 4A), arguing against a facile
explanation for the phenotype.
The observed decline in mitochondrial translation is
likely due to a dominant negative action of mtPABP1
through disruption of essential protein–protein interac-
tions in the poly(A) extension. Immunoprecipitation
with mtPABP1-FLAG clearly pulled down a level of
mitoribosome (Supplementary Figure S2), possibly
explaining the increase in immunoprecipitation of the
12S mt-rRNA (Figure 3B). However, all these data do
not completely negate the possibility of non-speciﬁc
binding of mt-RNA by mtPABP1 causing the inhibition
of translation. To address this issue, mutants of mtPABP1
were constructed with varying aﬃnities for RNA.
PABPC1 is a complex protein containing four
RNA-binding domains, RRM1-4 (25). Previous
mutagenic studies of yeast PAB1p had identiﬁed
mutants that showed markedly altered binding properties.
One such mutation, F366V (second aromatic residue in
RNP1 of RRM4) displayed only a 4-fold reduction in
poly(A) speciﬁc aﬃnity (KD 50nM) but with an immea-
surably weak aﬃnity for mixed RNA sequences. A
second, harbouring substitutions in positions Y83V
(RRM1) and F170V (RRM2), diminished poly(A)
MTRNR1
MTCO1
MTCO2
mtPABP1
mtLUC
12
AB
Figure 3. mtPABP1 binds mitochondrial mRNA. (A) RNA was isolated from cells expressing mtPABP1 over an 8-day period prior to the analysis
of poly(A) tail extensions as described (7).
32P-end-labelled products corresponding to the 30 termini of MTCO2 (lanes 1–6), MTCO1 (lanes 7–10)
and MTND4 (lanes 11–14) were separated through an 8% denaturing PAG and visualized by PhosphorImager and ImageQuant analysis. Zero
extension is taken as the position of migration predicted on 30 processing from the polycistronic transcript prior to any addition. Products were
generated in the absence of mtPABP1 expression (UP, lanes 3, 8 and 12) or after 1 (lane 4), 5 (lanes 5, 9 and 13) or 8 (lanes 6, 10 and 14) days
induction. MPAT assays were also performed on RNA isolated from cells expressing mtLUC for 8 days (L, lanes 1, 7 and 11). Lane 2 demonstrates
MPAT on RNA isolated from uninduced mtPABP1 transfectants grown in 1mg/ml ethanol for 8 days (UP ETOH). (B) Immunoprecipitated mtPABP1
associates with RNA. Immunoprecipitation of FLAG tagged mtLUC and mtPABP1 was performed as described in ‘Materials and Methods’ section.
Equal volumes of RNA extracted from immunoprecipitated samples were analysed by northern blot with the indicated probes as detailed in
‘Materials and Methods’ section.
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the equivalent critical residues in mtPABP1; F337V
(second aromatic residue in RNP1 of RRM4) and
Y56V/F142V (second residues of RNP1 of RRM1 and
RRM2, respectively) were generated as described in
‘Materials and Methods’ section. As shown in Figur 4B,
induced expression of the constructs resulted in com-
parable amounts of the chimeric proteins present in
protease K shaved mitochondria. Further, although a
similar increase in acidity was noted in culture media
after a 5-day induction of mtPABP1 and
mtPABP1(F337V), no such acidosis was noted with
mtPABP1(Y56V/F142V), consistent with OXPHOS
defects in cells expressing PABP1 that bound to
mt-mRNA poly(A) tails (data not shown).
To conﬁrm that poly(A) binding was essential for the
inhibition of protein synthesis, in vivo translation was per-
formed with cells expressing the mutated forms of
mtPABP1. As shown in Figure 4C, expression of
mtPABP1(Y56V/F142V), equivalent to the previously
characterized mutant PAB1p with more than 100-fold
decrease in poly(A) aﬃnity (25), caused only a marginal
translation defect (lane 3). Conversely, mtPABP1(F337V)
with a strong poly(A) aﬃnity but very limited non-speciﬁc
binding (25), consistently caused an even more profound
translation inhibition than mtPABP1 (Figure 4C, compare
lanes 4 and 2). This marked increase in inhibition over
wild-type mtPABP1 was possibly due to the absence of
any non-speciﬁc RNA binding, which could have partially
titrated the wild-type protein in the mitochondrial matrix.
12 4 3
12 4 3
12 4 3
RNA14
MTCO2
MTCO1
MTND3
MTRNR1
days
mtPABP1 mtLUC
03580358 358
1 5 3 4 6 2 77
F337V
91 0 11
D
95
72
52
34
mtLUC
mtPABP1
Y56V/F142V
F337V
mtPABP1
porin
IF3mt
kDa
C AB
mtLUC
Figure 4. Occlusion of the poly(A) tail inhibits mitochondrial translation. (A) In vivo mitochondrial translation assays were performed for 15min
(lanes 1 and 2) and 45min (lanes 3 and 4) exposure to
35S methionine/cysteine after expression of mtPABP1 (lanes 2 and 4) or mtLUC (lanes 1
and 3) for 5 days as described in ‘Materials and Methods’ section. Cell lysates (50mg) were separated through a 15% denaturing PAG, visualized and
quantiﬁed using ImageQuant software following exposure to a PhosphorImager cassette. Individual polypeptides were designated on the basis of
their mobility (20). To conﬁrm equal loading, a small section of the gel is shown after exposure following Coomassie staining. (B) mtPABP1 and
variants are expressed and imported into mitochondria with equal eﬃciency. Transfectants were induced for 3 days, mitochondria isolated and
proteinase K treated as described in ‘Materials and Methods’ section. Resulting mitochondrial lysates (10mg) were separated by 12% denaturing
SDS-PAGE. Western blots were performed with anti-FLAG antibody to detect mtPABP1 and variants. Equal loading was conﬁrmed using two
antibodies speciﬁc to mitochondrial proteins, the outer membrane protein VDAC (porin) and the soluble matrix marker translation initiation factor 3
(IF3mt). Molecular weight size markers are indicated. (C) Similar in vivo labelling experiments were performed (10-min pulse) on the indicated
transfectants after 3 days induction. Lysate (25mg) was separated and visualized as described in (A). Lane 3, variant mtPAPB1(Y56V/F142V); lane 4,
variant mtPABP1(F337V). (D) Induction of mtPAPB1 and variant mtPABP1(F337V) do not increase the turnover of mt-mRNA. RNA was isolated
from the indicated transfectants after 0-, 3-, 5- or 8-day induction and aliquots (10mg) subjected to northern blot analysis as detailed in ‘Materials
and Methods’ section. The indicated mt-mRNA probes were used. A probe to the 12S mt-rRNA (MTRNR1) was used as loading control.
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binding of foreign proteins to the poly(A) extensions of
mt-mRNA can substantially inhibit translation.
Binding of mtPABP1 does not cause destabilization of
mt-mRNA
A substantial decrease in protein synthesis occurs on
induction of mtPABP1 or the mutant mtPABP1(F337V).
Although this was likely to be due to poly(A) interaction it
was still possible that induction led to a decrease in
mt-mRNA stability with a consequent decrease in trans-
lation. To determine whether occupation of the 30 termini
by mtPABP1 may aﬀect the stability of mt-mRNA, total
cytoplasmic RNA was isolated from cells following 3, 5 or
8 days of induction and was assessed by northern blot
analysis. As shown in Figure 4D, expression of mutant
or wild type mtPABP1 did not cause any decrease in the
stability of mitochondrial encoded transcripts. Indeed, an
increased steady-state level was noted for some species on
induction of mtPABP1 (MTND3 171±10%; MTCO1
148±7%). The steady-state level of 12S rRNA
(MTRNR1) did not display any signiﬁcant changes with
the expression of either mtPABP1 form.
DISCUSSION
At steady state, human mt-mRNAs are virtually all oligo-
or polyadenylated. For seven of the 11 protein coding
transcripts, one function is clear; oligoadenylation at the
30 terminus is necessary to generate a complete UAA ter-
mination codon that is recognized by the single
mitochondrial release factor, mtRF1a. Has the
mitochondrial poly(A) polymerase (mtPAP) been
retained solely to provide this critical function, or is
polyadenylation necessary for other functions? The
standard approach to assess poly(A) function is to
prevent its synthesis by depleting mtPAP with siRNA,
an experiment that has been performed by two
laboratories which, although invariably producing
shortened poly(A) extensions unfortunately resulted in
conﬂicting conclusions, as mentioned in the introduction
(8,9). A second approach is to interfere with the turnover
of the poly(A) tail. To date, it is not clear which enzymes
are responsible for this important role. The core yeast
mitochondrial RNA degradosome consists of a helicase,
Suv3p and a ribonuclease, Dss1p (26). Although a human
Suv3p orthologue has been identiﬁed (27), no Dss1p
orthologue is present in the human genome. The human
polynucleotidyl phosphorylase (hPNPase) has been sug-
gested as a candidate. A report by Slomovic and
Schuster showed that downregulation of hPNPase can
cause a profound but unpredictable modulation of
poly(A) tail length of human mitochondrial mRNA (10).
No direct measurement of mt-mRNA stability was per-
formed, but mitochondrial translation was unaﬀected.
These authors showed that MTCO1 transcripts were
often correctly processed at their 30 termini but the
majority were not adenylated. Although there was a 30
addition of ribonucleotides, surprisingly these were
commonly found to be uridylates, but no evidence of
translation inhibition was noted for MTCO1.
Polyuridylation has also been found on incorrectly pro-
cessed intermediates and was suggested to tag incorrect
transcripts for degradation (28). This observation
prevents us from being able to eliminate this 30 extension
from playing an essential role in translation. This
intriguing data is further complicated by the report that
the substantial majority of hPNPase is not actually located
in the mitochondrial matrix but is in the intermembrane
space (29), eﬀectively separated from mitochondrial RNA,
raising the question of whether hPNPase is indeed
involved in poly(A) turnover in human mitochondria.
The approach taken in this report was to manipulate the
mt-mRNA poly(A) tail by targeting cytosolic poly(A)
modifying enzymes to the mitochondrion. Deadenylation
of mt-mRNAs by mtPARNC led to a decrease in
steady-state level of MTCO1, MTCO2 and RNA14,
similar to the previous report by Nagaike et al. (9) who
siRNA-depleted mtPAP. However, in contradistinction
we show that certain species are increased in abundance.
For example, MTND2 showed an almost 4-fold increase,
with MTND1 also markedly increased. These data argue
against a simple explanation that polyadenylation of
mt-mRNA always promotes stability. Indeed, our data
is similar to the variability in stability found by
Slomovic and Schuster (10) on depletion of human
PNPase. Further, we show that this variability is not
linked to translatability, as mitochondrial translation of
all species was decreased.
Our data with mtPABP1 shows that the poly(A) tail is
likely to be necessary for optimizing translation eﬃciency.
Poly(A) speciﬁc binding of the mutant F337V also
resulted in decreased translation rates of all mitochondrial
proteins, conﬁrming the decrease was linked to poly(A)
binding and not due to non-speciﬁc interactions. We
believe this is due to mtPABP1 competing for binding at
poly(A) region, indicating that poly(A) normally interacts
with endogenous components that promote translation.
Proteomics analysis of proteins bound to mt-mRNA
revealed some interesting candidates that may interact
with poly(A) in vivo. One candidate, SLIRP, was found
in all analyses (MW, RNL, ZMACL unpublished obser-
vation). This small RNA binding protein has one pre-
dicted RRM domain and has recently been shown to be
essential for RNA stability in mitochondria (30). Could
this protein be the elusive mitochondrial poly(A) binding
protein ? SLIRP and mt-mRNA were shown to be
mutually dependent. As the poly(A) extension is not essen-
tial for mt-mRNA stability, it is unlikely that the loss of a
poly(A) speciﬁc binding protein would lead to dramatic
loss of stability. A previous study reported tight binding of
SLIRP to RNA stem–loop structures, but it will be inter-
esting to determine whether the protein is also able to
recognize poly(A) sequences. As yet, we do not know
which aspect of mitochondrial translation is aﬀected by
mtPABP1 binding, initiation, elongation, termination or
recycling. Preliminary analysis of RNA proﬁles in
isokinetic density gradients suggest that on induction of
mtPABP1 the RNA occupancy of mitoribosomes is
decreased, whilst association with the small subunit is
3740 Nucleic Acids Research, 2010,Vol.38, No. 11increased, indicating that termination and recycling, at
least, are not aﬀected.
Finally, although mtPARN translation studies were
complicated by the loss of termination codons in most
transcripts, translational inhibition of MTCO1 was diﬃ-
cult to interpret, as sequence analysis revealed that almost
all transcripts retained a complete open reading frame.
Translation and membrane insertion of the yeast
COX1p orthologue requires the assistance of translational
activators [MSS51p (31), PET309p (32)] which interact
with UTRs of the COX1 transcript. Recently, a human
translational activator of MTCO1, TACO1, was identiﬁed
(33). Although it has yet to be formally shown, it is
possible that this protein interacts within this 30 UTR to
promote translation in an unspeciﬁed manner.
Consequently, the loss of this part of the MTCO1 tran-
script may result in the loss of the TACO1 interaction site
and therefore the loss of translation. A second protein,
LRPPRC, has been suggested to be the human orthologue
of another yeast translational activator, PET309 (34). This
human mitochondrial RNA binding protein has also been
implicated in MTCO1 association and a similar problem
may occur on loss of the 30 UTR.
In summary, our data strongly suggests that in addition
to being required for completing the termination codon of
7 ORFs, it is also required for the optimizing
mitochondrial protein synthesis.
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